You have no items in your shopping cart.
Cart summary
Rimonabant
Catalog Number: orb1308349
| Catalog Number | orb1308349 |
|---|---|
| Category | Small Molecules |
| Description | Rimonabant |
| Purity | 99.90% |
| MW | 463.79 |
| Biological Activity | Rimonabant (SR141716) is an inverse agonist for the cannabinoid receptor CB1. It is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. Its main avenue of effect is a reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. Rimonabant is approved in 38 countries including the E.U., Mexico, and Brazil. It was rejected for approval for use in the United States. |
| CAS Number | [168273-06-1] |
| Formula | C22H21Cl3N4O |
| SMILES | Cc1c(nn(c1-c1ccc(Cl)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCCCC1 |
| Storage | -20°C |
| Note | For research use only |
Rimonabant hydrochloride [orb1226082]
> 98%(HPLC)
158681-13-1
500.3
C22H22Cl4N4O
1 g, 5 mg, 500 mg, 25 mg, 50 mg, 10 mg, 100 mgRimonabant [orb1225972]
> 98%(HPLC)
168273-06-1
463.8
C22H21Cl3N4O
200 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 g, 500 mgRimonabant hydrochloride [orb1308356]
99.50%
[158681-13-1]
500.25
C22H22Cl4N4O
100 mg, 50 mg, 25 mg, 10 mg, 5 mg, 500 mg, 1 ml x 10 mM (in DMSO)
